openPR Logo
Press release

Acquired Immunodeficiency Syndrome (AIDS) Related Cancer Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

04-03-2019 02:51 PM CET | Health & Medicine

Press release from: Pharma Proff

Acquired Immunodeficiency Syndrome (AIDS) Related Cancer

Acquired immunodeficiency syndrome (AIDS) related cancer include those types of cancer which occurs in patients suffering from AIDS.

Download the sample report @ https://www.pharmaproff.com/request-sample/1110

People with AIDS are reported to be highly suspected to the occurrence of lymphomas. According to the American Society of Clinical Oncology, Kaposi sarcoma is very common in patients with AIDS; whereas non-Hodgkin’s lymphoma is second most common in patients with AIDS.

Get the detailed analysis @ https://www.pharmaproff.com/report/aids-related-cancer-therapeutics-pipeline-analysis

Women with AIDS are at high risk for developing cervical intraepithelial neoplasia. The National Cancer Institute is in the process of developing chemotherapy and HAART; and EPOCH-rituximab, for the treatment of AIDS related lymphoma.

Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1110

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acquired Immunodeficiency Syndrome (AIDS) Related Cancer Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments here

News-ID: 1686071 • Views:

More Releases from Pharma Proff

Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates. IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developments
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates. Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Pate …
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome. Download the sample report at: https://www.pharmaproff.com/request-sample/1189 Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant Growth due to Increasing Strategic Developments in the Coming Years | Top Players are Orphazyme A/S, IntraBio Ltd., CTD Holdings, Inc., Mallinckrodt Pharmaceuticals, SOM Biotec
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances

All 5 Releases


More Releases for AIDS

New Technologically Advanced and Customizable Hearing Aids Fuel the Growth of He …
Major players such as Sivantos Inc., Sonova Holding AG are focusing on product development and innovation to expand their sales network in emerging economies. For example, Sivantos Inc. has launched products with features such as Bluetooth connectivity, slick design, binaural listening technology, and customizable size as per user need. Also, in case of in-the-ear type of hearing aids, they provide features such as noise cancellation, vent for optimal ear ventilation. Request
Hearing Aids Market 2018-2025: by Products (Bone-Anchored Systems, Canal Hearing …
Hearing aid is a medical device used to amplify the sound so that the person can clearly hear. Various hearing aids products available in the market are bone-anchored systems, canal hearing aids, in-the-ear (ITE) hearing aids, cochlear implants, behind-the-ear (BTE) hearing aids, and receiver-in-the-ear (RITE) hearing aids among others. Technological advancements in hearing aids and rising incidences of hearing problems across the global population are the major drivers which are likely
Food Vacuum Sealers Market 2017 -Nesco, Henkelman, Packaging Aids, Promarks Inc, …
Global Food Vacuum Sealers Market Report 2017 provides detailed analysis of Food Vacuum Sealers market, enclosing detailed study of Food Vacuum Sealers market for last few years and forecast up to year 2022. The Food Vacuum Sealers market report analyses the global Food Vacuum Sealers market from different angles to understand various factors impacting the global Food Vacuum Sealers market. The reports enlightens the user with various applications, product type, end
M·A·C AIDS Fund and EAC Network Spread Holiday Cheer to People Living with HIV …
M·A·C Cosmetics’ employees joined EAC Network and prepared holiday meals for people with HIV/AIDS for World Aids Day on December 1st. The group volunteered on behalf of the M·A·C AIDS Fund, which provides grants and support to programs that perform vital services for those living with HIV/AIDS. EAC Network’s Nutrition Education and Food Services improves the lives of individuals living with HIV/AIDS through nutrition education and healthy food. The program runs the
Global Hearing Aids Market 2016: Digital hearing aids, Analog hearing aids
A hearing aid is an electronic device that amplifies the sound resulting in the production of clear sound for the user. These are largely deployed for people who suffer from hearing loss and impairment. The global Hearing aids market is gaining popularity owing to the rising technological innovations and increased demand for aesthetic designs of the devices. While the market is considered to be influenced by factors such as technological
First Colo GmbH supports the fight against AIDS – World AIDS Day 2010
Munich, 01.12.2010 The First Colo GmbH supports the association Rainbow e.V. and the advertising agency “Philipp und Keuntje GmbH”. Occasion for this action: the World AIDS Day 2010 on December, 1st. In collaboration with many sponsors a project called "Cock Out" originated successfully. Alongside an extensive information web site, several video spots have been aired already, primarily provocative – matching with the topic’s message “Anti-Aids”! Protect yourself and help us: every 15